# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-263335
Filing Date
2022-10-17
Accepted
2022-10-17 07:09:42
Documents
133
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F | d251611d20f.htm iXBRL | 20-F | 2866602
2 | EX-4.21 | d251611dex421.htm | EX-4.21 | 61636
3 | EX-4.22 | d251611dex422.htm | EX-4.22 | 60322
4 | EX-12.1 | d251611dex121.htm | EX-12.1 | 10345
5 | EX-12.2 | d251611dex122.htm | EX-12.2 | 10364
6 | EX-13.1 | d251611dex131.htm | EX-13.1 | 6043
7 | EX-15.1 | d251611dex151.htm | EX-15.1 | 2136
13 | GRAPHIC | g251611g0929152956548.jpg | GRAPHIC | 32493
14 | GRAPHIC | g251611g33f08.jpg | GRAPHIC | 3950
15 | GRAPHIC | g251611g51g95.jpg | GRAPHIC | 4165
| Complete submission text file | 0001193125-22-263335.txt |  | 11930051

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | kzia-20220630.xsd | EX-101.SCH | 109528
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | kzia-20220630_cal.xml | EX-101.CAL | 41949
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | kzia-20220630_def.xml | EX-101.DEF | 344278
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | kzia-20220630_lab.xml | EX-101.LAB | 576183
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | kzia-20220630_pre.xml | EX-101.PRE | 496735
127 | EXTRACTED XBRL INSTANCE DOCUMENT | d251611d20f_htm.xml | XML | 2413347

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 221312542
SIC: 2834 Pharmaceutical Preparations